Overall, our findings highlight a multi-omics signature for CAD, and this, in turn, suggests that disturbances in glycerophospholipid metabolism due to LPCAT1 genetic variants seem to be associated with the occurrence of CAD. Here, LPCAT1 is linked to coronary artery disorder.